Venous thromboembolism in trauma patients: A review

Surgery

Volumn 130, Issue 1, 2001, Pages 1-12

  Roger, Frederick B ^a  

^a FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; TINZAPARIN;

BLEEDING; DEEP VEIN THROMBOSIS; DIAGNOSTIC APPROACH ROUTE; DOSE RESPONSE; DRUG INDICATION; HUMAN; INCIDENCE; INJURY; LUNG EMBOLISM; MEDICAL DECISION MAKING; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SUBDURAL HEMATOMA; THROMBOEMBOLISM;

EID: 0034943450     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.114558     Document Type: Article

References (90)

1. The epidemiology of traumatic death: A population-based analysis
2. Pulmonary embolism following trauma
3. Venous thrombosis and pulmonary embolism: A clinicopathologic study in injured and burned patients
4. An analysis of 950 fatal injuries
5. Risk factors in pulmonary embolism
6. Thromboembolism following multiple trauma
7. Venous thromboembolism in patients with major trauma
8. A prospective study of venous thromboembolism after major trauma
9. Pulmonary embolism in major trauma patients
10. "False negatives" and "false positives" in acute pulmonary embolism: A clinical-postmortem comparison
11. Coagulation changes in elective surgery and trauma
12. Alterations in coagulation and fibrinolytic system in acute trauma
13. D-dimer levels correlate with pathologic thrombosis in trauma patients
14. Prophylactic vena cava filter insertion in severely injured trauma patients. Indicators and preliminary results
15. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis
16. Post trauma thromboembolism prophylaxis
17. Prevention of venous thromboembolism after injury: An evidence-based report - Part 11: Analysis of risk factors and evaluation of the role of vena cava filters
18. Silent deep vein thrombosis in immobilized multiple trauma patients
19. Deep vein thrombosis and pulmonary emboli in neurosurgical patients: A review
20. Roentgen diagnosis of venous thrombosis in the leg
21. Contrast venography of the leg: Diagnostic efficacy, tolerance, and complication rates with ionic and nonionic contrast media
22. Posttraumatic venous thrombosis
23. Systematic lower limb phlebography in acute spinal cord injury in 147 patients
24. The detection and management of proximal deep venous thrombosis in patients with acute acetabular fractures: A follow-up report
25. Detection of deep-vein thrombosis by real-time B-mode ultrasonography
26. Diagnosis of deep vein thrombosis in asymptomatic high-risk patients
27. Prospective ultrasound evaluation of venous thrombosis in high-risk trauma patients
28. Femoral catheters and deep venous thrombosis: A prospective evaluation with venous duplex sonography
29. Prevention of venous thromboembolism in trauma patients
30. Use of low molecular weight heparin in preventing thromboembolism in trauma patients
31. The urokinase pulmonary embolism trial. A national cooperative study
32. Complication and validity of pulmonary angiography in acute pulmonary embolism
33. The incidence etiology and avoidance of complications of pulmonary angiography in a large series
34. Value of the ventilation perfusion scan in pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis
35. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: A systematic review
36. Subsequent pulmonary embolism: Risk after a negative helical CT pulmonary angiogram-prospective comparison with scintography
37. Prevention of deep vein thrombosis with particular reference to mechanical methods of prevention
38. Effects of external pneumatic intermittent compression of fibrinolysis in man
39. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression
40. Pneumatic calf compression, fibrinolysis and the prevention of deep vein thrombosis
41. Hemodynamic and fibrinolytic consequences on intermittent pneumatic compression: Preliminary results
42. Reduction in fatal pulmonary embolism and venous thrombosis by preoperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery
43. A comparison of low-dose heparin with low-molecular weight heparin as prophylaxis against venous thromboembolism after major trauma
44. Asymptomatic deep venous thrombosis in the trauma patient: Is an aggressive screening protocol justified?
45. Efficacy of subcutaneous heparin in prevention of venous thrombosis in trauma patients
46. Prevention of venous thromboembolism after injury: An evidence-based report - Part 1: Analysis of risk factor and evaluation of the role of vena cava filters
47. Thromboembolism
48. Heparin and low molecular weight heparin for treatment of acute pulmonary embolism
49. Low-molecular weight heparins
50. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin
51. Comparison of subcutaneous unfractionated heparin of a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and a contraindication to Coumadin
52. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism
53. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis
54. Low molecular weight in the treatment of patients with venous thromboembolism
55. Cost-effective method for bedside insertion of vena cava filters in trauma patients
56. Twenty year clinical experience with the Greenfield filter
57. Bedside placement of inferior vena cava filters in the intensive care unit
58. Extended indication for placement of an inferior vena cava filter
59. Greenfield filter prophylaxis of pulmonary embolism in patients undergoing surgery for acetabular fracture
60. Surgical prophylaxis for pulmonary embolism
61. Use of the Greenfield filter in patients with major trauma
62. Risk factors associated with pulmonary embolism despite routine prophylaxis: Implications for improved protection
63. Prophylactic Greenfield filter placement in selected high-risk trauma patients
64. Routine prophylactic vena cava filter insertion in severely injured trauma patients decreases the incidence of pulmonary embolism
65. Expanded use of inferior vena cava filters in the trauma population
66. Prophylactic Greenfield filters: Acute complications and long term follow-up
67. Early placement of prophylactic vena cava filters in injured patients at higher risk for pulmonary embolism
68. Efficacy of prophylactic vena cava filters in high-risk trauma patients
69. The role of ultrasonography and inferior vena cava filter placement in high-risk trauma patients
70. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism
71. Clinical experience with temporary vena cava filters
72. Results of a multicenter study of the retrievable tulip vena cava filter: Early clinical experience
73. The tempofilter: A multicenter study of a new temporary caval filter implantable for up to six weeks
74. Inferior vena caval filter use in the US trauma centers: A practitioner's survey
75. Complication of anticoagulation for pulmonary embolism in low risk trauma patients
76. Heparin-induced thrombocytopenia and thrombosis
77. Heparin: Mechanism of action, pharmacokinetic, dosing considerations, monitoring, efficacy and safety
78. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
79. A diagnostic test for heparin-induced thrombocytopenia
80. Heparin associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen
81. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia
82. Can low molecular weight heparins and heparinoids be safely given to patients with heparin induced thrombocytopenia syndrome?
83. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients
84. Cost-effective prevention of pulmonary embolus in high-risk patients
85. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant respond to activate protein C; prediction of a cofactor to activated protein C
86. High-risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
87. World distribution of FACT V Leiden
88. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
89. Hyperchromocysteinemia as a risk factor for deep vein thrombosis